[关键词]
[摘要]
目的 探讨强脉冲光(IPL)、环孢素A滴眼液联合玻璃酸钠按特定时序组合的方案用于中重度睑板腺功能障碍(MGD)的临床价值及其安全性。方法 本研究纳入双眼均确诊为中重度MGD的患者200例(400眼),采用随机数字表结合密封信封法分为观察组与对照组,每组各100例(200眼)。观察组接受IPL照射治疗(共4次,每次间隔21天),同时按序贯方案给予环孢素A滴眼液(用药2个月)及玻璃酸钠滴眼液(全程使用6个月);对照组仅予上述两种滴眼液。主要评价指标为泪膜破裂时间(BUT)的变化,并比较睑酯分泌质量、视觉模拟评分(VAS)及以患者为单位的临床缓解率。采用广义估计方程(GEE)处理双眼数据的相关性。结果 观察组在治疗后第2个月及第6个月时的BUT延长幅度均显著大于对照组(GEE组间主效应P<0.01)。此外,观察组的睑酯分泌优良率(78.3% vs 51.1%)及患者临床缓解率(65.2% vs 38.6%)亦均高于对照组(P均<0.01);观察组6个月时的VAS评分更低(P<0.05)。结论 对于中重度MGD,IPL联合环孢素A及玻璃酸钠的序贯策略短期内改善泪膜稳定性和睑酯性状的效果优于单用药物,但其长期疗效和安全性尚需更多高质量研究验证。
[Key word]
[Abstract]
Objective This study aimed to assess the effectiveness and safety of a sequential regimen combining intense pulsed light (IPL), cyclosporine A, and sodium hyaluronate for patients with moderate-to-severe meibomian gland dysfunction (MGD). Methods A total of 200 patients (400 eyes) with bilateral moderate-to-severe MGD were enrolled and randomly assigned to an observation group or a control group (n=100 each) using a random number table and sealed envelopes. The observation group received IPL treatments (4 sessions at 21-day intervals) alongside cyclosporine A (for 2 months) and continuous sodium hyaluronate (for 6 months), while the control group received only the two eye drops. The primary outcome was the change in tear film break-up time (TBUT). Secondary outcomes included meibum quality, Visual Analog Scale (VAS) scores, and the per-patient clinical remission rate. Generalized estimating equations (GEE) were used to handle inter-eye correlation. Results The observation group showed significantly greater TBUT improvements at both 2 and 6 months (GEE main effect P<0.01). It also demonstrated superior meibum quality (78.3% vs. 51.1%) and a higher remission rate (65.2% vs. 38.6%, both P<0.01), along with lower VAS scores at 6 months (P<0.05). Conclusion The sequential IPL-cyclosporine-hyaluronate strategy offers short-term advantages over medication alone in improving tear stability and meibum quality for moderate-to-severe MGD, though its long-term efficacy and safety require further investigation.
[中图分类号]
[基金项目]